Effect of ketamine on glutamate release in cultured spinal astrocytes chronically treated with morphine / 中华麻醉学杂志

ABSTRACT

Objective Glutarnic acid, an important excitatory neurotransmitter, plays an important role in morphine dependence and tolerance. Astrocyte (AST) takes up giutamic acid which is transformed into glutamine, the precursor of GABA, by means of intracellular glutaminase. The aim of thin study was to investigate the effect of ketamine on glutamate release in cultured spinal ASTs chronically treated with morphine. Methods ASTs were isolated from 1-3 day old SD rats and divided into 8 groups control group and group A, B1, B2, B3 , C1, C2, C3. The isolated ASTs were cultured and incubated for 48h in the presence (group A, B1-3, C1-3) and absence (control group) of 10?mol?L-1 morphine.Then the ASTs were transferred to liquid culture medium Neurobasal / B27 containing no serum. No drug was added in group A. Morphine 0.1 ,1 or 10?mol?L-1 was added in group B1-3 and ketamine 0.4, 4 or 40?mol?L-1 in group C1-3. After being incubated for 15 min, naloxone 10?mol?L-1 was added in group B1-3 and C1-3. After another 30 min incubation the gluamate concentration in supernatant was measured using HPLC. Results There was no significant difference in glutamate concentration between control group and group A ( P